Korean J Vet Res.  2015 Dec;55(4):241-246. 10.14405/kjvr.2015.55.4.241.

Establishment of a live vaccine strain against fowl typhoid and paratyphoid

Affiliations
  • 1BioPOA Co., Yongin 17093, Korea.
  • 2Daesung Microbiological Lab. Co., Euiwang 16103, Korea.
  • 3Laboratory of Avian Diseases, College of Veterinary Medicine, Seoul National University, Seoul 08826, Korea.
  • 4Laboratory of Poultry Production Medicine, College of Veterinary Medicine, Seoul National University, Seoul 08826, Korea. kwonhj01@snu.ac.kr
  • 5Reserch Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University, Seoul 08826, Korea.

Abstract

To develop a live vaccine strain against fowl typhoid and paratyphoid caused by Salmonella serovar Gallinarum biovar Gallinarum (Salmonella Gallinarum) and Salmonella serovar Enteritidis (Salmonella Enteritidis), respectively, several nalidixic acid resistant mutants were selected from lipopolysaccharide (LPS) rough strains of Salmonella Gallinarum that escaped from fatal infection of a LPS-binding lytic bacteriophage. A non-virulent and immunogenic vaccine strain of Salmonella Gallinarum, SR2-N6, was established through in vivo pathogenicity and protection efficacy tests. SR2-N6 was highly protective against Salmonella Gallinarum and Salmonella Enteritidis and safer than Salmonella Gallinarum vaccine strain SG 9R in the condition of protein-energy malnutrition. Thus, SR2-N6 may be a safe and efficacious vaccine strain to prevent both fowl typhoid and paratyphoid.

Keyword

attenuation; fowl typhoid; live vaccine; paratyphoid; rough strain

MeSH Terms

Bacteriophages
Nalidixic Acid
Protein-Energy Malnutrition
Salmonella
Salmonella enteritidis
Typhoid Fever*
United Nations
Virulence
Nalidixic Acid
Full Text Links
  • KJVR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr